Thomas Smith, M.D.
Executive Vice President and Chief Medical Officer
Professional Overview
Thomas Smith, M.D., is a seasoned pharmaceutical executive with over two decades of experience driving medical and clinical strategy across the industry. As the Executive Vice President and Chief Medical Officer at Collegium Pharmaceutical, Inc., he spearheads the company's medical and scientific affairs, playing a pivotal role in advancing its pipeline of innovative pain management solutions.
Experience Summary
Current Role
In his current position at Collegium Pharmaceutical, Dr. Smith is responsible for overseeing all medical and scientific activities, including clinical development, medical affairs, and pharmacovigilance. He collaborates closely with cross-functional teams to ensure the safe and effective delivery of the company's products, contributing to its mission of addressing the significant unmet needs in pain management.
Career Progression
Prior to his role at Collegium, Dr. Smith served as the Chief Medical Officer at several leading pharmaceutical companies, including BioDelivery Sciences International, Charleston Laboratories, Inc., Ameritox, Mallinckrodt Pharmaceuticals, and Covidien Pharmaceuticals. Throughout his career, he has consistently demonstrated his ability to drive clinical and medical strategies that enhance patient outcomes and support the commercial success of pharmaceutical products.
Academic Background
Dr. Smith holds a Doctor of Medicine (M.D.) degree from the Indiana University School of Medicine, where he also completed his internship and residency in internal medicine at the Community Hospitals of Indianapolis. He earned his Bachelor of Science (B.S.) in Biology from Purdue University.
Areas of Expertise
- Pharmaceutical and biotechnology industry
- Pain management and specialty therapeutic areas
- Clinical development and medical affairs
- Regulatory strategy and compliance
- Cross-functional leadership and team management
Professional Impact
During his tenure, Dr. Smith has been instrumental in the successful development and commercialization of several pharmaceutical products, contributing to their regulatory approvals and market access. His deep clinical expertise, combined with his strategic vision and collaborative leadership, have consistently driven positive outcomes for the organizations he has served.
Conclusion
With his extensive industry experience, proven track record of success, and unwavering commitment to advancing patient care, Dr. Thomas Smith is poised to continue making significant contributions to Collegium Pharmaceutical's efforts to address the evolving needs of individuals living with chronic pain.
